GENDER DIFFERENCE AND COMORBIDITIES IN CHRONIC HEART FAILURE PATIENTS
https://doi.org/10.15829/1728-8800-2017-6-87-91
Abstract
Aim. Investigation and analysis of clinical-hemodynamic signs of chronic heart failure (CHF) at the age 42-89 y. o., including the assessment of gender and comorbidities, according to ejection fraction (EF) of the left ventricle (LV): preserved EF LV ≥45% (HFpEF) and low EF LV <45% (HFrEF).
Material and methods. Totally, 120 CHF patients studied, age 42-89 y. o., with assessment of gender and comorbidities, accoring to ejection fraction (EF) of the left ventricle (LV): preserved EF LV ≥45% (HFpEF) and low EF LV <45% (HFrEF).
Results. In most cases the etiology of CHF was coronary heart disease (CHF) — 58,8%, and in 68,3% cases it was comorbid with arterial hypertension (AH). Assessment of CHF in patients with various EF LV showed that in both groups males predominated. In HFrEF there were more overweight patients (41,1%) and in HFpEF — obesity patients (51,6%). In HFrEF patients main factors leading to myocardial impairment were myocardial infarctions in anamnesis (91,1%), and in HFpEF — CHD with AH (81,3%), obesity (51,6%) and diabetes (43,8%). Extracardiac comorbidity in HFrEF was mostly chronic obstructive pulmonary (26,8%) and obliterate atherosclerosis of lower extremities arteries (17,9%), and HFpEF — congestion pneumonia (23,4%) and varicose vein disease (34,4%).
Conclusion. Patients with HFrEF — are mostly the CHD patients having risk factors: smoking, alcohol overconsumption, excessive physical exertion. HFpEF patients are mostly CHD+AH, most of them had metabolic disorders. Most cases of varicose vein disease and pneumonia in HFrEF can be explained by obesity and increased rate of diabetes. Cases of vascular dementia in HFpEF patients are related to higher prevalence of AH and its complications.
Supporting agencies: heart failure; ejection fraction; left ventricle; comorbidity
About the Authors
R. T. Shukurov
JSC Republic Specialized Cardiology Center
Uzbekistan
Tashkent
Uzbekistan
Tashkent
T. A. Abdullaev
JSC Republic Specialized Cardiology Center
Uzbekistan
Tashkent
Uzbekistan
Tashkent
References
1. Cleland J., Swedberg K., Follath F. et al. The Euro Heart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003 Mar; 24 (5): 442-63.
2. Donald Lloyd, Robert J. Adams, Todd M. Brown, et al. Heart Disease and Stroke Statistics – 2010 Update. A Report from the American Heart Association. Circulation 2010; 121: 46-215.
3. Ageev FT, Danielyan MO, Mareev VYu et el. Patients with chronic heart failure in the Russian out-patient practice: features contingent, diagnosis and treatment (materials research ЭПОХА-О-ХСН). Heart failure 2004; 5 (1): 4-7. Russian (Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Больные с хронической сердечной недостаточностью в Российской амбулаторной практике: особенности контингента, диагностика и лечение (по материалам исследования ЭПОХА-О-ХСН). Сердечная недостаточность 2004; 5 (1): 4-7).
4. Shah A.D., Langenberg C., Rapsomaniki E. et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1,9 million people. Lancet Diabetes Endocrinol 2015; 3: 105–113.
5. Nagueh S., Bhatt R., Vivo R. et al. Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure. Circ Cardiovasc Imaging 2011; 4 (3): 220-227.
6. Klapholz M., Maurer M., Lowe A. et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 2004 Apr 21; 43 (8): 1432-8.
7. Nagueh S., Appleton C., Gillebert T. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10 (2): 165-193.
8. Ott A., Breteler M., van Harskamp F. et al. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998 Mar 15; 147 (6): 574-80.
9. Campbell P., Krim S., Ventura H. The Bi-Directional Impact Of Two Chronic Illnesses: Heart Failure And Diabetes — A Review Of The Epidemiology And Outcomes. Cardiac Failure Review 2015; 1 (1): 8–10.
10. Chuchalin AG, Seymach IY, Momot AP et el. Changes in systemic inflammatory and hemostatic reactions in patients with aggravation of chronic obstructive disease lungs with associated chronic heart failure and obesity. Pulmonology 2014; 6: 25–32. Russian (Чучалин А.Г., Цеймах И.Я., Момот А.П. и др. Изменения системных воспалительных и гемостатических реакций у больных с обострением хронической обструктивной болезни легких с сопутствующими хронической сердечной недостаточностью и ожирением. Пульмонология 2014; 6: 25–32).
11. Ginsburg MM, Kryukov NN. Obesity. Impact on the development of metabolic syndrome. Prevention and treatment. Moskow: Medpractice, 2002: 128. Russian (Гинзбург М.М., Крюков Н.Н. Ожирение. Влияние на развитие метаболического синдрома. Профилактика и лечение. М.: Медпрактика, 2002: 128).
12. National guidelines SSHF, RSC and RNMOT for the diagnosis and treatment of CHF (fourth revision). Heart failure 2014; № 7 (81): 379–472. Russian (Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Сердечная недостаточность 2014; № 7 (81): 379–472).
13. Belenkov YuN, Mareev VYu, Arutjunov GP et el. National guidelines for the diagnosis and treatment of chronic heart failure. Heart failure 2003; 4 (6): 276-297. Russian (Беленьков Ю.Н., Мареев В.Ю., Арутюнов Г.П. и др. Национальные рекомендации по диагностике и лечению ХСН. Сердечная недостаточность 2003; 4 (6): 276-297).
14. Discussion. Heart failure 2006; 7 (3): 145. Russian (Дискуссия. Сердечная недостаточность 2006; 7 (3): 145).
15. Guidelines of the European society of cardiology for the diagnostic and treatment of acute and chronic heart failure 2012. Russian cardiology journal 2012; 4 (102): 1-68. Russian (Рекомендации европейского общества кардиологов по диагностике и лечению острой и хронической сердечной недостаточности 2012. Российский кардиологический журнал 2012; 4 (102): 1-68).
16. Ageev FT, Danielyan MO, Mareev VY et el. The study ЭПОХА. Heart failure 2006; № 4; 3. Russian (Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Исследование ЭПОХА. Сердечная недостаточность 2006; № 4; 3).
17. Kenchaiah S., Evans J., Levy D. et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347 (5): 358-359.
18. Thomas J., Kelly R., Thomas S. et al. Utility of history, physical examination, electrocardiogram and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 2002 Apr 15; 112 (6): 437-45.
19. Mareev VY. The main achievements in the field of understanding, diagnostic and treatment of chronic heart failure in 2003 (part 1). Heart failure 2004; 5 (1): 25-31. Russian (Мареев В.Ю. Основные достижения в области понимания, диагностики и лечения ХСН в 2003 г. (часть 1). Сердечная недостаточность. 2004; 5 (1): 25-31).
20. Gaynitdinova ММ, Avdeev SN. Remodeling large peripheral artery in patients with chronic obstructive disease lungs and its combined with arterial hypertension. Pulmonology 2015; 1: 50–57. Russian (Гайнитдинова В.В., Авдеев С.Н. Ремоделирование крупных периферических артерий у больных хронической обструктивной болезнью легких и при ее сочетании с артериальной гипертензией. Пульмонология 2015; 1: 50–57).
21. Zadionchenko VS, Adasheva TV, Li VV et el. Arterial hypertension and chronic obstructive disease lungs – the problem of choice therapy. Attending physician 2012; 7: 77–81. Russian (Задионченко В.С., Адашева Т.В., Ли В.В. и др. Артериальная гипертензия и хроническая обструктивная болезнь легких — проблемы выбора терапии. Лечащий Врач 2012; 7: 77–81).
Review
For citations:
Shukurov R.T., Abdullaev T.A. GENDER DIFFERENCE AND COMORBIDITIES IN CHRONIC HEART FAILURE PATIENTS. Cardiovascular Therapy and Prevention. 2017;16(6):87-91. (In Russ.) https://doi.org/10.15829/1728-8800-2017-6-87-91
Views:
860
Email this article 
